Quirónsalud Zaragoza leads clinical trial in women with iron-deficiency anemia

• Grupo Hospitalario Quirón launched two hematology clinical research tracks at Quirónsalud Zaragoza, targeting iron-deficiency anemia in women, rare diseases.
• The hospital is leading a clinical trial in women with iron-deficiency anemia, aiming to improve tolerability, adherence, patient quality of life.
• A phase I-II gene-therapy trial in Gaucher disease type 1 has already had results presented at the European Hematology Association congress.
• The center is the only Spanish hospital to have enrolled patients in that gene-therapy study, positioning it as a reference site.
• The program supports access to innovative therapies locally, reinforcing the group’s research strategy with about 1,500 active clinical trials.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Grupo Hospitalario Quirón SA published the original content used to generate this news brief on September 02, 2026, and is solely responsible for the information contained therein.